- Biktarvy is a new regimen in one pill containing the following anti-HIV drugs: . bictegravir – 50 mg. TAF (tenofovir alafenamide) – 25 mg. FTC ...
- In cases of possible exposure to HIV, the use of PEP (post-exposure prophylaxis) has been found to greatly reduce the risk of HIV infection. For PEP to work, it ...
- Prezcobix is the brand name of a pill containing the anti-HIV drug darunavir and the boosting agent cobicistat. The purpose of cobicistat is to raise and ...
- Since 1996, the availability of potent combination anti-HIV therapy (ART) in Canada and many high-income countries has led to significantly reduced rates of ...
- As all people age they become at risk for developing illness related to the decline of important organ-systems. Some people with HIV appear to be at heightened ...
- On average, HIV-positive adults appear to be at increased risk for aging-related complications. One potential strategy to reduce this risk is to engage in ...
- Client PublicationThis resource provides basic information about pre-exposure prophylaxis (PrEP) for gay, bisexual and other men who have sex with men. It includes key messages on who should consider taking PrEP, how…
- CATIE NewsReports have suggested that HIV may be progressing more rapidly in Saskatchewan.. Researchers analyzed the genetic sequences of HIV among people in the ...
- In 2015, a pilot hepatitis C screening program was offered within a hospital-based community dental clinic in Italy. The program was called EASY HCV-test.
- A resource outlining the evidence in support of PNEPs and dispelling common myths about these programs.
- This brochure in Punjabi and English, offers basic information on hepatitis C and is intended for immigrants and newcomers from Punjab, India and the service ...